Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1995-01-13
1997-06-24
Phelan, D. Gabrielle
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
424404, 424411, 424446, 604360, 604904, A61F 1302
Patent
active
056415036
ABSTRACT:
Absorbent products, especially catamenial tampons, for absorbing body fluids, such as menstrual fluid, blood and wound exudates, comprise an amount of a compound effective to inhibit the production of toxic shock syndrome toxin-1 by Staphylococcus aureus bacteria when the products are brought into contact with the bacteria. The compound is selected from the group consisting of monoesters of a polyhydric aliphatic alcohol and a C.sub.8 -C.sub.18 fatty acid; diesters of a polyhydric aliphatic alcohol and a C.sub.8 -C.sub.18 fatty acid; and mixtures thereof. The monoesters and diesters have at least one hydroxyl group associated with their aliphatic alcohol residue.
REFERENCES:
patent: 3052607 (1962-09-01), Hirsh
patent: 3219525 (1965-11-01), Berkow et al.
patent: 3584119 (1971-06-01), Langley
patent: 3970759 (1976-07-01), Frankenfeld et al.
patent: 4022775 (1977-05-01), Kabara
patent: 4067997 (1978-01-01), Kabara
patent: 4113851 (1978-09-01), Leveen et al.
patent: 4347237 (1982-08-01), Evenstad et al.
patent: 4374522 (1983-02-01), Olevsky
patent: 4393871 (1983-07-01), Vorhauer et al.
patent: 4405323 (1983-09-01), Auerbach
patent: 4413986 (1983-11-01), Jacobs
patent: 4431427 (1984-02-01), Lefren et al.
patent: 4485029 (1984-11-01), Kato et al.
patent: 4551148 (1985-11-01), Riley et al.
patent: 4582717 (1986-04-01), von Bittera et al.
patent: 4585792 (1986-04-01), Jacob et al.
patent: 4722936 (1988-02-01), Jacob
patent: 4722937 (1988-02-01), Jacob et al.
patent: 4769021 (1988-09-01), Kass
patent: 4788060 (1988-11-01), Endicott et al.
patent: 4788180 (1988-11-01), Bloch
patent: 4921694 (1990-05-01), Hoppe et al.
patent: 4981686 (1991-01-01), Hardy
patent: 4997851 (1991-03-01), Isaacs et al.
patent: 5000749 (1991-03-01), Le Veen et al.
Material Safety Data Sheet for Leomin H5G-R, 1988.
Altenbern, Protease Inhibitors Suppress Enterotoxin B formation by Staphylococcus Aureus, FEMS Microbiology Letters 3 (1978) pp. 199-202.
Ansari et al., Sodium Bicarbonate Sodium Bicarbonate Douching for Improvement of the Postcoital Test, Fertility and Sterility, vol. 33, No. 6, (Jun. 1980) pp. 608-612.
Flournoy et al., The Role of Lauricidin as an Antimicrobial Agent, Drugs of Today, vol. 21, No. 8, (1985) pp. 373-377.
Gossel, Feminine Hygiene Products: Why Your Advice is Needed, U.S. Pharmacist, (May 1986), pp. 20-27.
Iandolo. Genetic Analysis of Extravellular Toxins of Staphylococcus Aureus, Annu. Rev. Microbiol. (1989) 43: pp. 375-402.
Iandolo et al., Regulation of Staphylococcal Enterotoxin B.sup.1, Infection and Immunity, vol. 16, No. 2, (May, 1977), pp. 610-616.
Ibrahim et al., Inhibition of Growth of Staphylococcus aureus and Enterotoxin-A Production in Cheddar Cheese Prod. with Induced Starter Failure, J. of Food Protec. vol. 44, No. 3, (Mar. 1981) pp. 189-193.
Kabara, Structure-function Relationships of Surfactants as Antimicrobial Agents, J. Soc. Cosmet. Chem., vol. 29, (Nov. 1978), pp. 733-741.
Notermans et al., Effect of Glyceryl Monolaurate on Toxin Production by Clostridium Botulinum in Meat Slurry, J. of Food Safety vol. 3, (1981), pp. 83-88.
Orden et al., Detect. of Staph. Enterotoxin and Toxic Shock Synd. Toxin-1 (TSST-1) by (1991), Immunoblot Comb. with a Semiautomated Electrophoresis System, J. of Immuno. Meth. V. 144, pp. 197-202.
Reiser et al., Prod. of Toxic Shock Synd. Toxin 1 by Staph. aureus Restricted to Endogenous Air in Tampons, J. of Cl. Microb., vol. 25, No. 8, (Aug. 1987), pp. 1450-1452.
Robbins et al., Produc. of Toxic Shock Synd. Toxin 1 by Staphy. aureus as Determined by Tampon Disk-Membrane-Agar Method, J. of Clin. Microbio., V. 25, No. 8, (Aug. 1987), pp. 1446-1449.
Schlivert, Staphy. Enterotoxi B and Toxic-Shock Synd. Toxin-1 are Significantly Assoc. With Non-Menstrual TSS, The Lancet, May 17, 1986, vol. 1, pp. 1149-1150, (Abstract).
Schlivert et al., Toxic Shock Synd. Staphylococcus Aureus: Effect of Tampons on Toxic Shock Synd. Toxin Production, Obstetrics & Glynecology, vol. 64, No. 5 (Nov. 1984), pp. 666-671.
Smith et al., Enterotoxin A Synthesis in Staphylococcus aureus: Inhibition by Glycerol and Maltose, J. of Gen. Microbiology, (1985), 132, pp. 3375-3380.
Smith et al., Effect of Glucose Analogs on the Synthesis of Staphylococcal Enterotoxin A, Journal of Food Safety 8, (1987), pp. 139-146.
Strobino et al., Exposure to Contraceptive Creams, jellies and Douches and their Effect on the Zygote, Society for Epidemiologic Research: Abstracts, pp. 434.
Tierno et al., In vitro Amplification of Toxic Shock Syndrome Toxin-1 by Intravaginal Devices, Contraception, vol. 31, No. 2 (Feb. 1985), pp. 185-194.
Garbe, et al., Staphy. aureus Isolates from Patients with Nonmenstrual Toxic Shock Synd., JAMA, May 3, 1985, 253 (17) pp. 2538-2542.
Humphreys, et al., Enterotoxin Production by Staphy. aureus Isolates from Cases of Septicaemia and from Healthy Carriers, J. Med. Microbiology, Mar. 1989, 28, (3) pp. 163-172.
Crass, et al., Involvement of Staphy. Enterotoxins in Nonmenstrual Toxic Shock Synd., J. Clin. Microbiol., Jun. 1986, 23, (6), pp. 1138-1139.
Mc-Neil-PPC, Inc.
Phelan D. Gabrielle
LandOfFree
Additives to tampons does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Additives to tampons, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Additives to tampons will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-147780